Procurement
Expert Panel
Create New Account
Login
logo
Report store
Insights
Survey
Consulting
Book discovery call
logo

India In-Vitro Diagnostics Industry Analysis till 2018

Accreditation and Automation to Drive Future Growth

Region:Asia

Product Code:KR90

Download Sample Report
Published On

October 2013

Total pages

129

About the Report

The report titled "India In-Vitro Diagnostics Industry Analysis till 2018 - Accreditation and Automation to Drive Future Growth" provides a comprehensive analysis of the various aspects such as market size of the India in-vitro diagnostics market, India immunochemistry market, India biochemistry market, India hematology market, India microbiology market, India blood gas and electrolyte market, India molecular diagnostics market, India urinalysis market and India coagulation market. The report also covers the market shares of major players in the immunochemistry, biochemistry and microbiology space as well as the overall in-vitro diagnostics market in India.
 
In-vitro diagnostics market in India, which has hugely been driven by the increasing number of lifestyle diseases, inclining preventive healthcare practices, mounting disposable incomes, government's initiatives and improving healthcare infrastructure, registered revenues of USD ~ million in FY'2013. With the advent of new varieties of diagnostic tests incorporating latest technology, the revenues increased by 25.8% compared to FY'2012, where the total revenues were USD ~ million. In-vitro diagnostics market in India is subject to a gamut of different factors, such as people with diabetes, heart, kidney and other infectious and lifestyle diseases, and the overall disposable incomes in the country, which play an important role in determining the revenues from various diagnostic segments. Immunochemistry was the largest contributing category in terms of revenue, having recorded sales of USD ~ million in fiscal year 2013, while biochemistry, hematology and microbiology also contributed a significant share to the overall revenues. The India in-vitro diagnostics market has grown at a CAGR of 19.4% from USD 303.2 million in FY'2007 to USD ~ million in FY'2013.
 
The in-vitro diagnostics market in India is comprised of various manufacturers that specialize in the development and production of diagnostic products in different segments. Along with the presence of leading diagnostic companies in the organized sector, market in India is also driven by the revenues of a huge number of manufacturers in the unorganized segment. Roche was the market leader in the overall IVD market India, while also dominating the immunochemistry and biochemistry segments in fiscal year 2013. In addition to the prevalence of several players in the organized segment, the market is also driven by the imports of numerous diagnostic products from China and other countries.
In-vitro diagnostics market in India has showcased several emerging trends over the past few years. Some of the most definitive of these trends has been the advent of decentralized testing, mounting automation in laboratories, increasing consolidation and preference for early detection of diseases. Several pathological labs have resorted to invest heftily, and have been adopting fully automated systems for diseases diagnosis. In light of this, the accuracy of test results has increased, while the turnaround times have declined significantly. Additionally, the growth of portable diagnostics devices has propelled the market for point of care testing in India.
 
The market for in-vitro diagnostics in India is changing at a brisk rate. Technological advancements, demand of diagnostic tests from an ever growing base of disease-ridden population, and people suffering from lifestyle diseases, as well as the transition of diagnostic product manufacturers from the unorganized to the organized segment have been significantly changing the market. Revenues from the in-vitro diagnostics market in India are expected to expand to USD ~ million in FY'2018, growing with a CAGR of ~% from FY'2013 to FY'2018.
 
Key Topics Covered in the Report:
- The market size of the India in-vitro diagnostics market.
- The market size of the India immunochemistry market.
- The market size of the India immunochemistry reagents and instruments.
- The market size of the India biochemistry market.
- The market size of the India hematology market.
- The market size of the India microbiology market.
- Market segmentation of the India in-vitro diagnostics market on the basis of type of tests, contribution from reagents and instruments, and contribution from urban and rural areas.
- Market segmentation of the India Immunochemistry market on the basis of contribution from reagents and instruments, ELISA kits and rapid tests, and the market segmentation of immunochemistry instruments and reagents by types of tests and end use.
- Market segmentation of the India biochemistry market on the basis of contribution from reagents and instruments.
- Market segmentation of the India hematology market on the basis of contribution from reagents and instruments.
- Market segmentation of the India microbiology market on the basis of contribution from reagents and instruments.
- Market segmentation of the India blood gas and electrolyte market on the basis of contribution from reagents and instruments.
- Market segmentation of the India molecular diagnostics market on the basis of contribution from reagents and instruments.
- Market segmentation of the India urinalysis market on the basis of contribution from reagents and instruments.
- Market segmentation of the India coagulation market on the basis of contribution from reagents and instruments.
- Trends and Development in the India in-vitro diagnostics market.
- Competitive landscape and detailed company profiles of the major manufacturers of diagnostics products in India
- Future outlook and projections of the India in-vitro diagnostics market.
 

Products

in-vitro diagnostics, immunochemistry, reagents and instruments, coagulation, biochemistry, hematology, microbiology, ELISA kits and rapid tests, micr

Companies

Roche Diagnostic, Abbott Laboratories, Transasia Biomedicals, Siemens Healthcare, Beckman Coulter, Becton and Dickinson and Sysmex

Table of Contents

1. India In-Vitro Diagnostics Market Introduction

Market Overview

Growth Drivers

Constraints

Regulatory Framework and Accreditation

2. India In-Vitro Diagnostics Market Size by Revenues, FY'2007-FY'2013

3. India In-Vitro Diagnostics Market Segmentation

3.1. By Reagents and Instruments, FY'2010-FY'2013

3.2. By Urban and Rural Areas, FY'2013

3.3. By Type of Tests, FY'2007-FY'2013

4. India Immunochemistry Market

4.1. Market Scenario

Market Overview

Drivers

Constraints

Emerging Technology Trends

4.2. India Immunochemistry Market Size, FY'2007- FY'2013

4.3. India Immunochemistry Market Segmentation Reagents and Instruments, ELISA Kits and Rapid Tests, FY'2007-FY'2013

4.3.1. India Immunochemistry Instruments and Reagents Market Size, FY'2007-FY'2013

4.3.2. India Immunochemistry Instruments and Reagents Market Segmentation By Type of Tests, FY'2007-FY'2013

4.3.3. India Immunochemistry Reagents Market Segmentation by End Use, FY'2007-FY'2013

4.4. Market Share of Major Players in India Immunochemistry Market, FY'2013

5. India Biochemistry Market

5.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

5.2. India Biochemistry Market Size, FY'2007 - FY'2013

5.3. India Biochemistry Market Segmentation by Reagents and Instruments, FY'2007-FY'2013

5.4. Market Share of Major Players in India Biochemistry Market, FY'2013

6. India Hematology Market

6.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

6.2. India Hematology Market Size, FY'2007-FY'2013

6.3. India Hematology Market Segmentation By Reagents and Instruments, FY'2007-FY'2013

6.4. India Hematology Market Competitive Landscape

7. India Microbiology Market

7.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

7.2. India Microbiology Market Size, FY'2007-FY'2013

7.3. India Microbiology Market Segmentation by Reagents and Instruments, FY'2008-FY'2013

7.4. Market Share of Major Players in India Microbiology Market, FY'2013

8. India Blood Gas and Electrolyte Market

8.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

8.2. India Blood Gas and Electrolyte Market Size, FY'2007 - FY'2013

8.3. India Blood Gas and Electrolyte Market Segmentation by Reagents and Instruments, FY'2007-FY'2013

8.4. Market Share of Major Players in India Blood Gas and Electrolyte Market, FY'2013

9. India Molecular Diagnostics Market

9.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

9.2. India Molecular Diagnostics Market Size, FY'2007 - FY'2013

9.3. India Molecular Diagnostics Market Segmentation by Reagents and Instruments, FY'2007-FY'2013

10. India Urinalysis Market

10.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

10.2. India Urinalysis Market Size, FY'2007 - FY'2013

10.3. India Urinalysis Market Segmentation by Reagents and Instruments, FY'2007-FY'2013

11. India Coagulation Diagnostics Market

11.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

11.2. India Coagulation Diagnostics Market Size, FY'2007 - FY'2013

11.3. India Coagulation Diagnostics Market Segmentation by Reagents and Instruments, FY'2007-FY'2013

12. India In-Vitro Diagnostics Market Trends and Developments

Mounting Demand for Decentralized Laboratory Tests

Increasing Penetration in Rural Areas

Early Detection as an Emerging Trend

Inclining Automation of Labs

Increasing Consolidation

Increasing Overseas Expansion

Inclining Prevalence of Hospital Laboratory Management (HLM)

13. Market Share of Major Players in India In-Vitro Diagnostics Market, FY'2013

14. Company Profiles of Major Players in India In-Vitro Diagnostics Market

15. India In-Vitro Diagnostics Market Future Outlook and Projections, FY'2014-FY'2018

15.1. Cause and Effect Relationship Analysis of the In-vitro Diagnostics Market in India

16. Macroeconomic and Industry Factors: Historical and Projections

16.1. Population in India, FY'2007-FY'2018

16.2. Personal Disposable Income in India, FY'2007-FY'2018

16.3. Consumer Expenditure on Healthcare in India, FY'2007-FY'2018

16.4. Government Expenditure on Healthcare in India, FY'2007-FY'2018

16.5. Foreign Direct Investments in Healthcare, FY'2008-FY'2013

16.6. Private Equity Investments in Healthcare, 2009-2012

17. Appendix

17.1. Market Definitions

17.2. Abbreviations

17.3. Research Methodology

Data Collection Methods

Approach

Variables (Dependent and Independent)

Final Conclusion

17.4. Disclaimer

Why Buy From Us?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022